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Abstract
Background: Caspases belong to a class of cysteine proteases which function as critical effectors
in cellular processes such as apoptosis and inflammation by cleaving substrates immediately after
unique tetrapeptide sites. With hundreds of reported substrates and many more expected to be
discovered, the elucidation of the caspase degradome will be an important milestone in the study of
these proteases in human health and disease. Several computational methods for predicting caspase
cleavage sites have been developed recently for identifying potential substrates. However, as most
of these methods are based primarily on the detection of the tetrapeptide cleavage sites - a factor
necessary but not sufficient for predicting in vivo substrate cleavage - prediction outcomes will
inevitably include many false positives.
Results: In this paper, we show that structural factors such as the presence of disorder and
solvent exposure in the vicinity of the cleavage site are important and can be used to enhance
results from cleavage site prediction. We constructed a two-step model incorporating cleavage site
prediction and these factors to predict caspase substrates. Sequences are first predicted for
cleavage sites using CASVM or GraBCas. Predicted cleavage sites are then scored, ranked and
filtered against a cut-off based on their propensities for locating in disordered and solvent exposed
regions. Using an independent dataset of caspase substrates, the model was shown to achieve
greater positive predictive values compared to CASVM or GraBCas alone, and was able to reduce
the false positives pool by up to 13% and 53% respectively while retaining all true positives. We
applied our prediction model on the family of receptor tyrosine kinases (RTKs) and highlighted
several members as potential caspase targets. The results suggest that RTKs may be generally
regulated by caspase cleavage and in some cases, promote the induction of apoptotic cell death - a
function distinct from their role as transducers of survival and growth signals.
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Open AccessConclusion: As a step towards the prediction of in vivo caspase substrates, we have developed an
accurate method incorporating cleavage site prediction and structural factors. The multi-factor
model augments existing methods and complements experimental efforts to define the caspase
degradome on the systems-wide basis.
Background
It is increasingly being recognized that proteolytic
processing, or the specific and limited cleavage of
proteins by enzymes called proteases, represents an
important mechanism for cellular control in all living
organisms [1]. Elucidating the protease degradome - the
complete substrate repertoire of the protease in a cell,
tissue or organism - at the systems level will unravel
important clues on protease function across biological
pathways and inter-connections with other protease
systems. However, the experimental discovery and
validation of bona fide protease substrates require time
consuming and laborious efforts. As such, computa-
tional tools for the prediction of protease degradomes
will complement these efforts.
In recent years, much work had been done on the
prediction of the substrates of caspases - a unique class
of cysteine proteases which function as critical effectors
of apoptosis, inflammation and other important cellular
processes [2-4]. Caspases recognizes highly specific
tetrapeptide motifs (denoted as P4-P3-P2-P1) and cleave
substrates after the requisite Asp residue at P1 [5].
Substrates of caspases belong to a myriad of protein
classes such as structural elements of the cytoplasm and
the nucleus, components of the DNA repair machinery,
protein kinases, GTPases and viral structural proteins
[6,7]. Hundreds of caspase substrates have been reported
and many more are expected to be discovered. Most of
the current approaches for caspase substrates prediction
are primarily based on the detection of cleavage sites on
proteins using information encoded within the tetrapep-
tide motifs (reviewed in [8]). While the identification of
the specific cleavage site on the primary sequence of a
protein is necessary for substrate prediction, it is intuitive
that the final proteolytic cleavage of a protein in vivo is
contingent on a multitude of other factors in addition to
the presence of cleavage sites. Based on our analysis on a
dataset of 176 experimentally verified caspase substrates
(details are available in Additional File 1), we found that
80% of substrates contain at least one other identical
caspase cleavage site sequence which is not reported as a
true cleavage site in the literature. Identical cleavage site
sequences in Tpr (DDED
2117) [9], p28BAP31 (AAVD
163)
[10-12], golgin 160 (SEVD
311)[ 1 3 ] ,T o p oI( P E D D
123)
[14,15] and heterogeneous nuclear ribonucleoparticle
C1/C2 (GEDD
305) [16], are located at two distinct
positions on the respective protein but only one was
reported to be cleaved. Indeed, it is suggested that
conformation of the local structure of the cleavage site
and not just the primary sequence alone is required for
protease cleavage. Unstructured regions of substrates
appear to be more susceptible to cleavage than regions of
secondary structure (helices and b-sheets) [8]. Also, the
structures of a number of in vivo caspase substrates such
as Bid [17,18], ICAD [19,20] and pro-caspase-7 [21,22]
suggest that caspase cleavage sites have a preference for
location within disordered or unstructured extended
loops, in line with observations on protease substrates in
general [23]. It is also suggested that the location of
cleavage sites is critical for substrate cleavage - a potential
cleavage site needs to be located at the surface of the
substrate, rather than within the hydrophobic core of the
protein, in order to be accessible to the protease active
site [24].
In this context, we are motivated to explore the
integration of these structural factors with cleavage site
prediction to better predict caspase substrates. We report
that caspase cleavage sites have a higher propensity to
locate in unstructured and solvent exposed regions on
the substrate compared to non-cleavage sites. We
propose a two-step, multi-factor model incorporating
these factors together with the caspase cleavage sites
prediction tools to augment the prediction of caspase
substrates. When CASVM [25,26] and GraBCas [27] were
integrated into the model, prediction results were shown
to achieve greater positive predictive values compared to
CASVM or GraBCas alone. The model was able to reduce
t h ef a l s ep o s i t i v ep o o lb yu pt o1 3 %a n d5 3 %
respectively while retaining all true positives. In addi-
tion, we applied our prediction model on the family of
receptor tyrosine kinases (RTKs) and highlighted several
members as potential caspase targets. The results suggest
that RTKs may be generally regulated by caspase
cleavage, and in some cases, promote the induction of
apoptotic cell death - a function distinct from their role
as transducers of survival and growth signals.
Results
Structural tendencies of caspase cleavage sites
We explored the likelihood for caspase cleavage sites to
locate in unstructured segments spanning across the
tetrapeptide recognition sequence on the folded protein.
To measure the propensities for various secondary
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dataset of 24-mer peptide subsequences comprising of
the tetrapeptide cleavage sites or randomly selected
tetrapeptide sequences on the same protein plus
upstream ten residues up to P14 and downstream ten
r e s i d u e su pt oP 10’ was constructed. Secondary structural
elements in these subsequences were predicted using
SABLE II protein structure prediction server (see Materi-
als and methods for details). The propensities for
secondary structures were quantified as Hp,E p and
Cp scores for helices, b-strands and coils respectively. As
shown in Figure 1A, the propensity for coils was
significantly greater for cleavage site subsequences
compared to non-cleavage site subsequences (mean
Cp =0 . 7 6v e r s u sC p = 0.51 respectively, P-value < 0.01),
while the propensity for helices was greater for non-
cleavage site subsequences compared to cleavage site
subsequences (mean Hp =0 . 4 3v e r s u sH p =0 . 2 1
respectively, P-value < 0.01). The distribution of cleavage
site subsequences and non-cleavage site subsequences
were further analyzed across Cp bins (Figure 1B). It was
shown that cleavage site subsequences were distributed
more frequently to bins of higher Cp scores compared to
non-cleavage site subsequences. Most cleavage site sub-
sequences were confined to bins 0.8-1.0 while a greater
proportion of non-cleavage site subsequences were
distributed to bins less than 0.8.
Next, we asked if cleavage sites would preferentially locate
in solvent exposed regions of substrates. The solvent
accessibilities of the 24-mer peptide subsequences from
the analysis dataset were predicted using the SABLE II
server. Sp, a composite variable for measuring the
propensity for solvent exposure was calculated for all
subsequences. As shown in Figure 2A, cleavage site
subsequences were more exposed to solvent compared to
non-cleavage site subsequences (mean Sp =0 . 5 0v e r s u sS p =
0.43 respectively, P-value < 0.01). When the distribution of
the subsequences were analyzed across Sp bins (Figure 2B),
both cleavage and non-cleavage site subsequences were
found to be increasingly distributed into regions of greater
solvent exposure as Sp increases from 0 to 0.40. However,
distribution of non-cleavage site subsequences peaked at Sp
of 0.40, while the distribution for cleavage site subse-
quences peaked at 0.60, before falling off along the higher
Sp bins values. Taken together, these results suggest that
caspase cleavage sites tend to locate in unstructured and
solvent exposed regions on substrates. Interestingly, we
further noted a positive correlation (overall correlation
coefficient, r = 0.43) between Sp and Cp values across
all cleavage site and non-cleavage site subsequences
(Figure 3A and 3B), further confirming the tendency for
cleavage sites to locate in regions with both characteristics
and vice versa.
Multi-factor model for prediction of caspase substrates
As noted earlier, the distinguishing factor for caspase
substrate cleavage is the presence of specific tetrapeptide
sequences on the substrate protein. However, the usage
of tetrapeptide specificities solely for detection of in vivo
substrate cleavage is likely to produce a high percentage
of false positives. With the exception of GraBCas and
CASVM, computational tools for caspase cleavage sites
prediction rely strictly on these tetrapeptide sequences in
their algorithms. The GraBCas software utilizes position
specific scoring matrices (PSSM) and accounts for the
tetrapeptide sequences and the downstream P1’ and P2’
residues. CASVM was developed recently by our group,
based on the support vector machine (SVM) algorithm
Figure 1
Propensity for cleavage sites to occur in secondary
structures. A. Propensities for different secondary
structure elements (coils,C p; helices,H p; b-strands,E p)w e r e
measured for 24-mer subsequences with or without caspase
cleavage sites (labelled “cleavage sites” and “non-cleavage sites”
respectively). B.Distribution of“cleavagesites” and “non-cleavage
sites”subsequencestoCpbins.EachCpbin(0.10,0.20...1.00)was
allocated a proportion ofsequences with Cp scores falling within
the bin range (0-0.10, 0.11-0.19...0.91-1.00).
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cleavage sites are employed. Given that bona fide
cleavage sites tend to locate in unstructured and solvent
exposed regions, we hypothesized if structural factors
c a nb eu s e dt oi m p r o v et h ep r e d i c t i o no fc a s p a s e
substrates by filtering out predicted cleavage site
sequences with unfavourable structural characteristics.
Accordingly, we propose a prediction model for caspase
substrates using a two-step approach to encapsulate
t h e s ef a c t o r s( F i g u r e4 ) .I nt h ef i r s ts t e p ,t h ee n t i r e
protein is scanned for potential caspase cleavage sites
using a caspase cleavage site prediction tool (a 24-mer
scanning window in CASVM is used as example). In the
second step, 24-mer subsequences - comprising of the
predicted cleavage sites with flanking ten residues
downstream and upstream from the tetrapeptide
sequence (P14 to P10’)-w e r ec o n s t r u c t e da n dC p and
Sp values calculated. The Cp and Sp values are combined
into the variable P-score, which quantifies the net
propensities for both unstructured regions and solvent
exposure in the subsequences. Using an assigned P-score
cut-off, cleavage sites in subsequences scoring above the
cut-off are selected while the rest are eliminated.
To measure effectiveness of the model in improving
caspase substrate prediction, CASVM and GraBCas were
implemented into the model and tested with an
independent dataset. In our earlier work, we reported
that CASVM, using the support vector machines algo-
rithm, achieved an accuracy of 89% when tested on an
independent dataset of caspase cleavage sites. GraBCas,
on the other hand, utilizes position-specific scoring
matrices for scoring and selecting potential tetrapeptide
sequences and achieved an accuracy of 70% (at cut-off of
0.1) using the same dataset. Stepping through the first
step of the model, CASVM predicted 80 tetrapeptide
Figure 2
Propensity for cleavage sites to occur in solvent
accessible locations. A. Propensities for solvent
accessibilities (Sp) were measured for 24-mer subsequences
with or without caspase cleavage sites (labelled “cleavage
sites” and “non-cleavage sites” respectively). B. Distribution
of “cleavage sites” and “non-cleavage sites” subsequences to
Sp bins. Each Sp bin (0.10, 0.20...1.00) was allocated a
proportion of sequences with Sp scores falling within the bin
range (0-0.10, 0.11-0.19...0.91-1.00).
Figure 3
Scatter plots of Sp and Cp values. Each data point
corresponds to the Sp and Cp values of a single 24-mer
subsequence of A. cleavage sites and B. non-cleavage sites.
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cleavage sites, inclusive of all 17 cleavage site sequences
from the test dataset, while GraBCas predicted 223
tetrapeptide sequences which included 15 of the 17
cleavage sites. At the second step, subsequences were
constructed as described and calculated for their P-score
values. Retention of subsequences at P-score cut-off
values from 0 to 1.00 was measured. Subsequences
containing cleavage sites were assigned as “true posi-
tives” and all other subsequences were assigned as “false
positives”. As shown in Figure 5A, all CASVM predicted
subsequences were retained at P-score of 0 but were
steadily eliminated as the cut-off progressed to 1.00. In
addition, from P-score cut-off of 0.15 to 0.80, propor-
tionately more true positives were retained compared to
the false positives. At P-score of 0.50, about 88% of true
positives were retained but more than half of the false
positives were eliminated. Similarly, all GraBCas pre-
dicted subsequences were eliminated in tandem with
increasing P-score cut-offs and proportionately more true
positives were retained from P-score cut-off of 0.25 to
0.80 compared to the false positives (Figure 5B). At
P-score of 0.50, 100% of true positives were retained but
more than half of the false positives were eliminated.
These metrics suggest that a defined range of P-score cut-
offs can be used to discriminate and filter the false
positives from cleavage site prediction. Interestingly, the
GraBCas results showed that false positives were filtered
off at P-score cut-off of 0.20 onwards while true positives
were eliminated only at a higher cut-off of 0.55. When
CASVM was used, false positives were filtered off from
P-score cut-off of 0.15 and true positives from 0.35. The
higher P-score cut-off for true positives compared to the
false positives in both cases further suggest that a notable
proportion of false positives - up to 13% and 53% in
CASVM and GraBCas models respectively - can be
eliminated without a reduction in the size of the original
pool of true positives. In addition, from the prediction
results, we measured the positive predictive value (PPV)
at each P-score cut-off for models implementing CASVM
and GraBCas (Table 1, denoted under CASVM-model and
GraBCas-model respectively). The usage of CASVM alone
obtained a PPV of 21.25%, while GraBCas achieved
6.73% (results are given under P-score cut-off of 0).
Notably, while the usage of either methods on its own
could predict most, if not all of the cleavage sites, the
relatively low PPV values intuitively suggest a proportio-
nately greater number of false positive cleavage sites.
However, the proportion of false positives can be
reduced in the multi-factor model implementing
CASVM or GraBCas since higher P-score cut-offs were
correlated with higher PPV values for both cases. Taken
together, these results indicate that the combination of
structural factors such as unstructured regions and
solvent exposure can be used to refine results from
cleavage site prediction by specific filtering of false
positives cleavage sites at defined P-score cut-off levels.
The reduction of the false positives cleavage sites will
lead to more accurate prediction of caspase substrates.
Prediction of caspase cleavage of RTKs
Receptor tyrosine kinases (RTKs) belong to a sub-class of
the protein kinase superfamily which function as plasma
membrane-bound receptors transducing extracellular
signals mediating cell survival, proliferation, embryonic
development, adult homeostasis and many other critical
processes [28]. As RTK activity in resting, normal cells is
tightly controlled, mutations or structural aberrations in
RTKs were shown to convert them to potent oncopro-
teins, contributing to the development and progression
of many cancers. Interestingly, recent studies have
implicated several members of the receptor tyrosine
kinase (RTK) family - as such EGFR [29,30], Erbb2
Figure 4
Schematic diagram of the multi-factor model for
caspase substrate prediction. Step1: A window scans the
entire protein (example used: 14-3-3, Uniprot ID: P31946)
for potential caspase cleavage sites (bold, underlined, P1
residue to the left of inverted triangle) using a caspase
cleavage site prediction tool (example used: a 24 residue
scanning window from CASVM). Step 2: 24-mer
subsequences containing predicted cleavage sites with
flanking ten residues downstream and upstream from the
tetrapeptide sequence (P14 to P10') are constructed. Cp, Sp
and P-score are calculated for all subsequences. Cleavage
sites in subsequences with P-score above the assigned cut-off
are selected.
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Result of model prediction on test dataset. A. CASVM predicted cleavage sites were assigned to pools containing
“true positives” or “false positives”. Fractions of cleavage sites in their respective pools (vertical axis) with P-scores above
the cut-offs (horizontal axis) were measured. B. GraBCas predicted cleavage sites were assigned to pools containing
“true positives” or “false positives”. Fractions of cleavage sites in their respective pools (vertical axis) with P-scores above
the cut-offs (horizontal axis) were measured.
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proteolytic targets of caspases during apoptosis. Given
the pervasive role of RTKs in cell survival and prolifera-
tion pathways and their implications in diseases such as
cancer, it is tempting to speculate if RTKs may be
generally regulated by caspase activity and if many other
RTKs remain hitherto undiscovered downstream targets
of caspases. Accordingly, we applied the multi-factor
model to predict for potential caspase substrates among
the members of the RTK family and analyzed the results.
The complete repertoire of RTK sequences - 52 members
across 16 sub-families, as listed in the KEGG database
[39] - was retrieved from Uniprot database [40] and
predicted for potential caspase substrates using the
multi-factor model. Protein sequences of RTKs were
submitted to the CASVM server under default settings
and predicted cleavage sites were scored for their
propensities for solvent exposure and unstructured
regions as described earlier. Predicted cleavage sites
with equal or less than the P-score cut-off of 0.3 were
highlighted (results are listed in Additional File 2;
P-score of 0.3 was chosen as it represented the highest
possible cut-off before true positives were filtered as
shown in Figure 5A). The results showed that all RTKs
were predicted to possess caspase cleavage sites which
are distributed throughout the length of the extracellular
and intracellular regions of the RTKs. About 92% of all
RTKs (48/52) possess cleavage sites on the intracellular
region while about 98% (51/52) contain extracellular
cleavage sites. While predicted cleavage sites localize
throughout the length of the receptors, notable trends in
the distribution of predicted sites imply functional
significance downstream of caspase cleavage. A sizeable
number of RTKs (~21%) were predicted for caspase
cleavage sites at the juxtamembrane region on the
cytoplasmic side of the receptors (defined as the receptor
segment between the transmembrane and kinase
domains). Interestingly, it was reported that caspase
cleavage of MET receptor at Asp
1000 results in the
inactivation of functional MET receptor by loss of its
signalling cytoplasmic domain, with the concomitant
appearance of membrane bound MET and soluble
intracellular MET fragments. The membrane-bound
MET fragment prevents downstream survival activity by
trapping its cognate ligand, while the intracellular MET
fragment becomes ligand-independent. It is conceivable
that caspase cleavage at the juxtamembrane sites on RTKs
may lead to the truncation of the full length receptor
into a membrane bound portion and an intracellular
fragment, similar to the observation of MET cleavage. In
addition, studies on caspase-cleaved RTKs suggest that
intracellular RTK fragments may have downstream
functional implications. The release of MET fragment
containing the active kinase domain following caspase
cleavage was shown to be pro-apoptotic in cells. Pro-
apoptotic intracellular fragments were similarly observed
downstream of caspase-mediated RET and Erbb2 clea-
vage as well. Observations on high-throughput proteo-
mic screening of caspase substrates in Dix et al. [41]
reported that a substantial number of caspase substrates
are cleaved into persistently stable, domain-containing
fragments, and further speculated that caspase-mediated
proteolysis yields a class of effector protein fragments
with novel functions. Also, caspase cleavage of ALK was
found to unravel a pro-apoptotic intracellular region
upstream of the cleavage site. Taken together, the
presence of predicted juxtamembrane cleavage sites on
the intracellular domain of the receptors indicate
possible receptor cleavage which could lead to the
interference of receptor signalling and the generation of
pro-apoptotic signals.
On a related note, close to 80% (41/52) of all RTKs
harbour caspase cleavage sites within the tyrosine kinase
domain of the receptor. In particular, RTKs from the
insulin receptor and FGF receptor sub-families are
annotated with multiple cleavage sites within their
tyrosine kinase domains. As these domains serve as key
mediators of signal transduction for RTKs, structural
alterations from caspase cleavage may lead to perturba-
tions of downstream RTK signalling. Interestingly,
studies by Tikhomirov et al. [42] indicate that proteolytic
fragments bearing the motif “RLLGI” derived from the
tyrosine kinase domains of EGFR, Erbb2, Erbb4, TrkA
a n dV E G F R 1w e r ea b l et oi n d u c ea p o p t o s i si nc e l l s .
Table 1: Positive predictive values (PPV) of model prediction at
various P-score cut-offs
PPV (%)
1
P-score CASVM-Model GraBCas-Model
0.00 21.25 6.73
0.05 21.25 6.73
0.10 21.25 6.73
0.15 21.52 6.73
0.20 21.79 6.79
0.25 22.37 7.08
0.30 23.61 7.25
0.35 23.53 8.06
0.40 24.19 9.62
0.45 27.78 10.79
0.50 32.61 13.39
0.55 31.58 12.77
0.60 39.29 18.64
0.65 53.85 24.14
0.70 80.00 30.77
0.75 100.00 42.86
1PPV calculations are limited to P-score cut-off of 0.75 as all predicted
cleavage sites were eliminated beyond this point for both models.
CASVM-Model and GraBCas-Model indicate the use of either CASVM or
GraBCas at the first step of the model.
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kinase domains of some of these receptors (EGFR;
Asp
770,A s p
916, Erbb4; Asp
878,A s p
922 and VEGFR1;
Asp
958,A s p
987 Asp
1135), suggesting the possibility of
caspase cleavage and release of pro-apoptotic intracel-
lular kinase fragments. As the “RLLGI” motif is suggested
to be prevalent among RTKs, it is possible that cleavage
of the tyrosine kinase domains of several other RTKs
c o u l dl e a dt ot h es i m i l a rp r o d u c t i o no fs u c hp r o -
apoptotic fragments. Studies on Erbb2 cleavage have
shown that caspase cleavage produced pro-apoptotic
intracellular fragments downstream of the kinase
domain in the C-terminal region of the receptor.
Cleavage of EGFR at a comparable location was shown
but no pro-apoptotic consequences were reported.
Interestingly, the other members of the EGFR family,
Erbb3 and Erbb4, were predicted to possess similarly
located caspase cleavage sites, suggesting that these
proteins could be caspase targets as well.
The presence and distribution of these predicted cleavage
sites across the RTK family suggest a general role of
caspase cleavage in regulating RTK function. It is
tempting to speculate a phenomenon whereby caspase
cleavage of RTKs leads to a molecular “life-death” switch
which converts the pro-survival protein to a pro-
apoptotic one through the exposure and/or the release
of pro-apoptotic domains. The elegant integration of
both anti- and pro-apoptotic functionalities on the same
signalling protein is an uncommon but economical
feature. As discussed in Fischer et al.[ 7 ] ,s u c hd r a m a t i c
reversal of protein function was similarly observed in the
caspase cleavage of serine/threonine protein kinases,
MEKK1 and MEKK4, which generated pro-apoptotic
fragments upon cleavage at their kinase domains. Several
other anti-apoptotic proteins such as Bcl-2 and Bcl-xl
have been shown to be converted into pro-apoptotic
molecules by caspase cleavage.
Intriguingly, most RTKs were predicted to harbour
caspase cleavage sites on their extracellular domain. It
is tempting to question if there are hitherto uncharacter-
ized functional consequences of cleavage at these
locations since all known substrate cleavage were
reported to be localized only in the intracellular
environment. Notably, active caspases were found to
be released into the extracellular environment during
apoptosis [43]. In addition, work by Cowan and co-
workers [44] provided evidence for the localization of
active caspase-2, caspase-3 and caspase-7 to the mem-
brane surfaces of apoptotic smooth muscle cells. Clearly,
future investigations on caspase activity in the extra-
cellular environment will shed light on the possibility of
extracellular RTK cleavage and its downstream conse-
quences. More importantly, the predicted cleavage sites
on RTKs will generate useful hypotheses and experi-
mental leads for the validation and characterization of
caspase-mediated RTK regulation.
Discussion
In this paper, we propose a multi-factor model for the
prediction of caspase substrates using a two-step
approach. The entire protein sequence is first scanned
for potential cleavage sites using a caspase cleavage sites
prediction algorithm. The predicted cleavage sites will be
filtered using a scoring system (given as the P-score)
which is based on the propensities of predicted cleavage
sites to locate in unstructured (Cp) and solvent exposed
regions (Sp) on the protein. Expert domain knowledge or
user requirements will direct the appropriate selection of
the P-score cut-off levels. We have adopted the use of
secondary structure and solvent accessibilities prediction
tools as there are very limited experimentally verified
structures on caspase substrates. As the model is
dependent on the accuracy of existing secondary
structure and solvent accessibility prediction tools,
advancements in these domains will be helpful for this
purpose.
Recently, the incorporation of additional factors, such as
secondary structures and solvent accessibilities, was
found to increase accuracy in HIV protease substrates
prediction [45]. In that case, a three-level hierarchical
classifier scans a protein sequence for HIV protease
cleavage sites using specificity data and filters the output
for sequences located within disorganized secondary
structures and solvent exposed regions. These structural
factors were similarly integrated with the neural network
algorithms for RNA and DNA binding sites prediction
and were found to be helpful [46,47]. In our proposed
method, instead of combining the prediction of cleavage
sites specificity, secondary structures and solvent acces-
sibilities into a single predictor, these factors were
accounted in two distinct steps to address a couple of
caveats implicit in protease substrate prediction. While
cleavage sites were shown to preferentially locate in
unstructured and solvent exposed regions, not all
predicted cleavage sites with substantial propensity for
these factors will be cleaved in vivo. It is conceivable that
regulatory processes such as post-translational modifica-
tions and other protein-protein interactions will likely to
influence the final proteolytic event. Conversely, pre-
dicted cleavage sites which are hidden in deep hydro-
phobic cores of proteins - hence characterized by low
propensities for solvent exposure - cannot be ruled out as
it is possible that these sequences may be exposed
following an upstream proteolytic cleavage of the
protein by the same or another protease. Evidently, the
caspase-mediated cleavage of ETK (epithelial and
BMC Genomics 2009, 10(Suppl 3):S6 http://www.biomedcentral.com/1471-2164/10/S3/S6
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a two-step fashion where the first caspase cleavage site of
the protein exposes an internal cleavage site for a
subsequent round of cleavage [48]. The retinoblastoma
protein, RB, the hepatocyte growth factor receptor, MET
and GTP exchange factor for small G-protein Ras,
RasGAP were all shown to be cleaved sequentially at
multiple sites - further suggesting the possibility of
structural changes following an upstream proteolytic
cleavage event (reviewed in [7]). To circumvent these
constraints, the proposed two-step model predicts for a
broad pool of potential cleavage sites in the first step and
filters the results through the P-score cut-off which can
be appropriately assigned with expert domain knowl-
edge or under different user requirements.
The two-step model was tested using two caspase
cleavage site prediction methods - CASVM and GraBCas.
It was shown that in both cases, the discrimination of
predicted cleavage sites based on additional structural
characteristics was helpful for reducing the false posi-
tives. The GraBCas-based model was shown to outper-
form the CASVM-based model by eliminating a greater
percentage of false positives with full retention of true
positives. A likely reason for the disparity in the results
could be due to the different sequence windows used for
prediction in each case. GraBCas requires only the
tetrapeptide cleavage sequence, while a 24-mer peptide
sequence (tetrapeptide sequence with flanking ten
residues upstream and downstream) is needed for
input into CASVM. Presumably, in the latter case,
information encoded within factors for caspase cleavage
site recognition would have overlapped to a greater
extent or are more correlated with that for secondary
structures and solvent exposure due to the longer
sequence window. In any case, the results suggest that
other cleavage sites prediction tools utilizing algorithms
with low correlation with secondary structure and
solvent accessibility prediction could be integrated into
the model. Conversely, the addition of other factors with
low correlations with cleavage site recognition would be
helpful for improving prediction of substrate cleavage.
Recent studies have suggested that exosites - or interac-
tion sites distal from the enzyme active site - could
mediate substrate cleavage and are responsible for non-
canonical caspase substrate cleavage. Structural studies
by Agniswarmy et al. [49] highlighted a symmetrical
pentapeptide binding pocket on caspase-7 situated way
from the active site which could function as an exosite.
Exosites were also shown to be involved in proteolytic
events mediated by blood coagulation proteases [50].
Similarly, it was reported that post-translational events
such as serine phosphorylation of caspase cleavage sites,
particularly on the P4 and P1’ residues [51,52], and
sumolyation [53] were inhibitory to substrate cleavage. It
is likely that models incorporating these factors with
existing caspase cleavage site prediction tools will
enhance in vivo substrate prediction. As the prediction
of other protease substrates is likely to be largely
influenced by the set of factors similar to the ones
suggested here, our proposed multi-factor model may be
applicable to the prediction of other protease substrates
given the required data.
Conclusion
In this paper, we analyzed the structural characteristics of
reported caspase substrates and found that caspase cleavage
sites are more likely to locate in unstructured and solvent
exposed regions compared to non-cleavage sites. We
hypothesized that the integration of these factors with
cleavage sites prediction will improve substrate prediction
by filtering out predicted cleavage site sequences with
unfavourable structural characteristics. Consequently, we
constructed a two-step model integrating these factors with
existing cleavage sites prediction tools. Using an indepen-
dent dataset of caspase substrates, the model incorporating
CASVM or GraBCas was shown to achieve greater positive
predictive values compared to these methods alone, and
was able to reduce the false positives pool by up to 13%
and 53% respectively while retaining all true positives. As
the prediction of other protease substrates is likely to be
largely influenced by the set of factors similar to the ones
suggested here, the multi-factor prediction model may be
applicable to the prediction of other protease substrates.
Future progress in computational prediction of caspase
substrates, and possibly for other protease-substrate
system, will clearly hinge on the careful selection and
integration of factors for substrate cleavage. It is certain
that such efforts will be greatly assisted as more data,
such as resolved structures of caspase substrates,
becomes available. As high through-put screening efforts
by Mahrus et al.[ 5 4 ]a n dD i xet al. [50] have uncovered
several hundred more caspase substrates over the past
year - an apparent indication of the burgeoning potential
for future discovery of novel substrates - it is expected
that in silico work will continue to complement experi-
mental studies in the challenging journey of defining the
caspase degradome on the systems-wide basis.
Materials and methods
Dataset
74 unique, experimentally verified cleavage sites were
obtained from the dataset of caspase cleavage sites
derived from Fischer et al. [7] (available in Additional
File 3). 24-residue long subsequences comprising of the
tetrapeptide sequence with flanking upstream 10 resi-
dues and downstream 10 residues (P14....P4P3P2P1......
P10’) were extracted from the respective substrates and
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tetrapeptide (not a verified cleavage site) was randomly
selected on the respective substrate of each verified
cleavage site and subsequences similar in length to the
“cleavage site” subsequences were constructed. A total of
74 additional subsequences were constructed and
designated as the “non-cleavage site” subsequences.
Together, the pool of subsequences (148 in total)
constitutes the analysis dataset and was used for the
analysis of structural features and for the optimization of
the prediction model parameters.
Quantitative measures of secondary structures and
solvent accessibilities
Each subsequence in the analysis dataset was predicted
for secondary structures and solvent accessibilities using
the SABLE II protein structure prediction server (using
default parameters; server located at http://sable.cchmc.
org) [55-57]. The SABLE server output was parsed with
Perl scripts and quantitative measures of the propensities
for helices (Hp), b-strands (Ep), coils (Cp)a n ds o l v e n t
accessibilities (Sp) were computed using the following
equations:
H
Hn N
N
p =
∑1
E
En N
N
p =
∑1
C
Cn N
N
p =
∑1
S
Sn N
Smax
p =
∑1
Hn,E n,C n and Sn are the SABLE predicted output for
helix, b-strand, coil and real-value score (ranging 0 to 6;
0 for fully buried and 6 for maximum exposure) for
solvent accessibility for each residue at position n in the
sequence of length N ( 1 ,2 ,3 . . . .N). Smax is a constant
with value of 144, which is the sum of real-value scores
from SABLE II for all residues in the 24-mer subsequence
assuming that each residue is maximally exposed to
s o l v e n t( 2 4×6=1 4 4 ) .
P-score, the quantitative measure of the net propensities
for both unstructured regions and solvent exposure on a
subsequence is given as:
PS c o r e C S pp −= + αβ
The P-score is the weighted sum of Cp and Sp values
where the weights are given by the coefficients a and b
respectively. Using the analysis dataset, values of a and b
were optimized to 0.3 and 0.7 respectively. Optimal a
and b coefficient values were obtained by stepping
through various combinations of values (0.0, 0.1,
0.2....1.0), and measuring the fraction of cleavage site
subsequences and non-cleavage site subsequences
retained at increasing P-score cut-offs (details are
available in the Additional File 4).
Multi-factor model testing
For model testing, a test dataset of unique caspase
cleavage sites (14 caspase substrates containing 17
unique cleavage site sequences; available in Additional
File 3) was used. The test dataset was predicted for
caspase cleavage sites using CASVM (P14P10’ scanning
window and P1 residue (Asp) options were selected) or
GraBCas (cleavage sites were scored using the GraBCas
matrices and the highest score was selected; cut-off of 0.1
was used). Predicted caspase cleavage sites were extracted
from substrate sequences and 24-mer subsequences
comprising of the predicted tetrapeptide sequences
with flanking upstream ten residues and downstream
ten residues (P14....P4P3P2P1......P10’) were constructed
and calculated for Sp,C p and P-score values. Subse-
quences containing the cleavage sites were assigned as
“true positives” while those containing non-cleavage
sites were denoted as “false positives”. Percentage of
subsequences from both pools retained at each P-score
cut-off (0.00, 0.05, 0.10...1.00) and corresponding
positive predictive values (PPV) were calculated for
both models. In this context, PPV measures the prob-
ability of hitting a true cleavage site when restricted to all
predicted cleavage sites and is computed as TP/(TP+FP),
where TP and FP are the number of “true positives” and
“false positives” respectively.
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Note
Other papers from the meeting have been published as
part of BMC Bioinformatics Volume 10 Supplement 15,
2009: Eighth International Conference on Bioinfor-
matics (InCoB2009): Bioinformatics, available online
at http://www.biomedcentral.com/1471-2105/10?
issue=S15.
BMC Genomics 2009, 10(Suppl 3):S6 http://www.biomedcentral.com/1471-2164/10/S3/S6
Page 10 of 12
(page number not for citation purposes)Additional material
Additional file 1
Matrix showing global mapping of reported caspase cleavage sites
across all known substrates. Each cell in table shows the frequency of
occurrence of an experimentally verified caspase cleavage site sequence
(column) in a known substrate (row). Coloured cell indicates frequency
of occurrence of that sequence in the substrate (yellow, 1; orange, 2; red,
3 and above).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-S3-S6-S1.xls]
Additional file 2
Global mapping of predicted caspase cleavage sites on receptor
tyrosine kinases. Positions of CASVM predicted cleavage sites on protein
sequence of each RTK member are listed. Numbers indicate the positions
of P1 (Asp) residues on protein sequences. All cleavage site positions are
color coded; grey indicates location of cleavage site within the
extracellular domain, blue indicates location within intracellular
domain and darker blue indicates location within kinase domain (all
kinase domains of RTKs are located in the intracellular domain of the
receptor). Predicted cleavage sites corresponding to true experimentally
verified cleavage sites on EGFR, ERBB2, MET, ALK and RET are
underlined. Yellow highlights indicate predicted cleavage sites with P-
score of 0.3 or smaller.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-S3-S6-S2.pdf]
Additional file 3
Analysis dataset of caspase substrate cleavage sites. List of caspase
substrate cleavage sites used for the analysis of structural features and for
the optimization of the prediction model parameters. Cleavage sites are
reported as tetrapeptides in the order: P4-P3-P2-P1. All cleavage sites
have an Asp (D) in the P1 position. The position of the P1 amino acid in
the protein sequence is given as reported in Uniprot.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-S3-S6-S3.pdf]
Additional file 4
Optimization of a and b coefficients in the P-score function.P o o l so f
cleavage site subsequences (74) and non-cleavage site subsequences
(74) were assigned with P-score values using different combinations of a
and b coefficient values (1.0 to 0.0 and 0.0 to 1.0 respectively). The two
pools were measured for the fraction of subsequences (vertical axis) with
scores above the P-score cut-offs (horizontal axis) (blue line: cleavage
site subsequences, red line: non-cleavage site subsequences, green line:
all subsequences) using the different combinations of a and b
coefficients (Figures A-K). The values of 0.3 and 0.7 were selected for a
and b coefficients respectively as the resultant P-score function produced
the best combination of cleavage site subsequences retention and
elimination of non-cleavage site subsequences under increasing P-score
cut-offs.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-S3-S6-S4.pdf]
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